Patent · US Active

Methods and systems for toxin delivery to the nasal cavity

US9700707B2 · kind B2 · utility

33Cited by
58References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 31, 2015
Grant dateJul 11, 2017
Priority date
Expiry dateAug 31, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y304/24069
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and systems for delivering toxin and toxin fragments to a patient's nasal cavity provide for both release of the toxin and delivery of energy which selectively porates target cells to enhance uptake of the toxin. The use of energy-mediated delivery is particularly advantageous with light chain fragment toxins which lack cell binding capacity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.